These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 7786883)

  • 21. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats.
    Jeong CY; Choi JI; Yoon MH
    Eur J Pharmacol; 2004 Oct; 502(3):205-11. PubMed ID: 15476746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vagal control of the heart: central serotonergic (5-HT) mechanisms.
    Jordan D
    Exp Physiol; 2005 Mar; 90(2):175-81. PubMed ID: 15604109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference.
    Popova NK; Tsybko AS; Naumenko VS
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies].
    Adrien J
    J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals.
    Pierce PA; Xie GX; Peroutka SJ; Green PG; Levine JD
    J Pharmacol Exp Ther; 1995 Oct; 275(1):502-8. PubMed ID: 7562592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors.
    Hoyer D
    Neuropsychopharmacology; 1990; 3(5-6):371-83. PubMed ID: 2078273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S
    Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin receptor ligands and the treatment of obesity.
    Vickers SP; Dourish CT
    Curr Opin Investig Drugs; 2004 Apr; 5(4):377-88. PubMed ID: 15134278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biology of serotonin receptors.
    Baez M; Kursar JD; Helton LA; Wainscott DB; Nelson DL
    Obes Res; 1995 Nov; 3 Suppl 4():441S-447S. PubMed ID: 8697042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies.
    Mann JJ; Arango V; Marzuk PM; Theccanat S; Reis DJ
    Br J Psychiatry Suppl; 1989 Dec; (8):7-14. PubMed ID: 2692642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of serotonin in memory impairment.
    Buhot MC; Martin S; Segu L
    Ann Med; 2000 Apr; 32(3):210-21. PubMed ID: 10821328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serotonin receptor subtypes. Considerations on their physiological role and therapeutic prospects].
    Di Renzo G; Marino A
    Clin Ter; 1990 Apr; 133(1):3-7. PubMed ID: 2140742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats.
    Aulakh CS; Mazzola-Pomietto P; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1994 Oct; 271(1):143-8. PubMed ID: 7965707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
    Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
    Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.